Kena Hudson just previewed the new Elizabeth Holmes documentary for MD+DI — and she says it delivers three wild hours of surprises and seriously uncomfortable moments.
Theranos fatigue is real for plenty of people — but tell that to the sold-out theaters in the Bay Area.
So, the question is: are you still invested in the Elizabeth Holmes story, or have you had enough?
👀 Kenna's full breakdown is coming soon — and she's bringing in other voices from the industry to dig into the lasting legacy of Elizabeth Holmes and what it means for medtech.
Stay tuned.
Drop your thoughts below: watching it, or over it?
#ElizabethHolmes #Theranos #MedTech #MDDI #Documentary #HealthTech #IndustryInsights
Abortion is a fundamental right for all women. It must be protected. I wish to express my solidarity with the women whose liberties are being undermined by the Supreme Court of the United States.
How can #health#research guide effective health communications?
Our own @heatherpierce71 shares five key points to help brands better handle #COVID19 uncertainty & #misinformation, while remaining mindful of all populations. Read more: https://t.co/1jD3W7puPS
Missing the camaraderie of #JPM21 and sharing best practices, tips and tricks with healthcare PR folks. Thanks to @BusinessWire and @Onclusive for inviting me to participate in some discussions. https://t.co/avzcNq4CCS
Blend art and science in biotech and healthcare #PR with performance metrics and context. 5 great ways to make your press release do more from @onclusive CEO Dan Beltramo and @Fleishman SVP @prkena#HealthcarePR#BiotechPR#PR#PRtips https://t.co/MNfkFljEtv
The situation in California is grim. Daycare centers are shutting because they can't ventilate. Restaurants can't serve outdoors. Asthma sufferers are isolated. Doctors are anxious.
"It’s suffocating physically and mentally, and we don’t have control.”
https://t.co/4tDtfezuZN
Interested in working in FleishmanHillard’s SF office? Applications for the 2020-21 Alfred Fleishman Diversity Fellowship are now open. Learn more about the opportunity. https://t.co/pLJshyCBIp
Big discussion at #JPM20: Maybe we should sit down and define digital health. There’s too much variability and it’s confusing. E.g. wellness apps are being bucketed in the same category as an FDA-cleared medical wearable prescribed by doctors.
@statnews Today I had the opportunity to hear Dr. Sandra Horning, an advisor for EQRx speak @womeninbio, she shared her passion, purpose and persistence for putting patients first. #JPM20